Lamichhane Gopal, Lee Da-Yeon, Franks Rienna, Olawale Femi, Jin Jong-Beom, Egan Josephine M, Kim Yoo
Department of Nutritional Sciences, Oklahoma State University, Stillwater, OK 74078, USA.
Laboratory of Clinical Investigation, National Institute on Aging, Baltimore, MD 21224, USA.
Biology (Basel). 2024 Jun 26;13(7):472. doi: 10.3390/biology13070472.
The high incidence of metabolic syndrome in the elderly poses a significant challenge to the healthcare system, emphasizing the need for interventions tailored to geriatric patients. Given the limited focus on females in previous studies, this research aimed to evaluate the effects of dietary curcumin on obesity and NAFLD outcomes in naturally aged (18-month-old) female mice.
Female C57BL/6 mice aged 18 months were fed a normal chow diet (NCD) and a HFHSD, with or without curcumin (0.4% /), for an 8-week period. Parameters included food intake, body weight, insulin tolerance test (ITT), glucose tolerance test (GTT), percentage fat mass, hepatic triglyceride, and cholesterol levels, and a histological examination for NAFLD detection, qPCR, and immunoblotting analyses were performed.
The cumulative body weight gain after 8 weeks in the aged female mice supplemented with curcumin and fed an HFHSD was significantly lower (10.84 ± 1.09 g) compared to those fed a HFHSD alone (15.28 ± 1.26 g). Curcumin supplementation also resulted in reduced total body fat (HFHSD group 50.83 ± 1.71% vs. HFHSD+CUR 41.46 ± 3.21%), decreased epidydimal fat mass (HFHSD: 3.79 ± 0.29 g vs. HFHSD+CUR: 2.66 ± 0.30 g), and repaired adipogenic signaling in the white adipose tissue. Furthermore, curcumin lowered triglyceride and cholesterol deposition in the liver, preventing hepatic steatosis and improving hepatic insulin sensitivity.
Curcumin demonstrates the ability to ameliorate the deleterious effects of HFHSD in aged female mice by reducing body fat composition, modulating adipogenic signaling in the white adipose tissue, and improving insulin homeostasis and non-alcoholic fatty deposition in the liver.
老年人中代谢综合征的高发病率给医疗保健系统带来了重大挑战,这凸显了针对老年患者制定干预措施的必要性。鉴于以往研究对女性的关注有限,本研究旨在评估膳食姜黄素对自然衰老(18个月大)雌性小鼠肥胖和非酒精性脂肪性肝病结局的影响。
18个月大的雌性C57BL/6小鼠被喂食正常饲料(NCD)和高脂高糖饮食(HFHSD),其中一组添加姜黄素(0.4%/),另一组不添加,持续8周。记录食物摄入量、体重、胰岛素耐量试验(ITT)、葡萄糖耐量试验(GTT)、脂肪量百分比、肝甘油三酯和胆固醇水平,并进行用于非酒精性脂肪性肝病检测的组织学检查、qPCR和免疫印迹分析。
与仅喂食HFHSD的老年雌性小鼠相比,补充姜黄素并喂食HFHSD的小鼠在8周后的累积体重增加显著更低(10.84±1.09克 vs. 15.28±1.26克)。补充姜黄素还导致总体脂肪减少(HFHSD组为50.83±1.71%,而HFHSD+CUR组为41.46±3.21%),附睾脂肪量减少(HFHSD组:3.79±0.29克 vs. HFHSD+CUR组:2.66±0.30克),并修复了白色脂肪组织中的脂肪生成信号。此外,姜黄素降低了肝脏中甘油三酯和胆固醇的沉积,预防了肝脂肪变性并改善了肝脏胰岛素敏感性。
姜黄素能够通过减少体脂成分、调节白色脂肪组织中的脂肪生成信号以及改善胰岛素稳态和肝脏中的非酒精性脂肪沉积,减轻HFHSD对老年雌性小鼠的有害影响。